Cargando…

Influence of Vitamin C on Lymphocytes: An Overview

Vitamin C or ascorbic acid (AA) is implicated in many biological processes and has been proposed as a supplement for various conditions, including cancer. In this review, we discuss the effects of AA on the development and function of lymphocytes. This is important in the light of cancer treatment,...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Gorkom, Gwendolyn N. Y., Klein Wolterink, Roel G. J., Van Elssen, Catharina H. M. J., Wieten, Lotte, Germeraad, Wilfred T. V., Bos, Gerard M. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874527/ https://www.ncbi.nlm.nih.gov/pubmed/29534432 http://dx.doi.org/10.3390/antiox7030041

Ejemplares similares

Haploidentical transplantation in patients with multiple myeloma making use of natural killer cell alloreactive donors
por: Van Elssen, Catharina, et al.
Publicado: (2020)

Low Levels of Serum and Intracellular Vitamin C in Hospitalized COVID-19 Patients
por: Boerenkamp, Lara S., et al.
Publicado: (2023)

The Effect of Vitamin C (Ascorbic Acid) in the Treatment of Patients with Cancer: A Systematic Review
por: van Gorkom, Gwendolyn N.Y., et al.
Publicado: (2019)

No Effect of Vitamin C Administration on Neutrophil Recovery in Autologous Stem Cell Transplantation for Myeloma or Lymphoma: A Blinded, Randomized Placebo-Controlled Trial
por: van Gorkom, Gwendolyn N. Y., et al.
Publicado: (2022)

Real‐world experience: Introduction of T cell replete haploidentical transplantations in a single center
por: van Gorkom, Gwendolyn, et al.
Publicado: (2021)

Defucosylation of Tumor-Specific Humanized Anti-MUC1 Monoclonal Antibody Enhances NK Cell-Mediated Anti-Tumor Cell Cytotoxicity
por: Gong, Ying, et al.
Publicado: (2021)

The impact of donor type on resource utilisation and costs in allogeneic haematopoietic stem cell transplantation in the Netherlands
por: van Gorkom, Gwendolyn, et al.
Publicado: (2022)

Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination
por: Oth, Tammy, et al.
Publicado: (2016)

Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
por: Gong, Ying, et al.
Publicado: (2021)

Bone marrow produces sufficient alloreactive natural killer (NK) cells in vivo to cure mice from subcutaneously and intravascularly injected 4T1 breast cancer
por: van Gelder, Michel, et al.
Publicado: (2016)

Rosuvastatin Enhances VSV-G Lentiviral Transduction of NK Cells via Upregulation of the Low-Density Lipoprotein Receptor
por: Gong, Ying, et al.
Publicado: (2020)

Easy-to-Use HPLC Method to Measure Intracellular Ascorbic Acid Levels in Human Peripheral Blood Mononuclear Cells and in Plasma
por: van Gorkom, Gwendolyn, et al.
Publicado: (2022)

Hypoxia Induced Impairment of NK Cell Cytotoxicity against Multiple Myeloma Can Be Overcome by IL-2 Activation of the NK Cells
por: Sarkar, Subhashis, et al.
Publicado: (2013)

P1368: NKG2A DELETION IN HUMAN NATURAL KILLER CELLS ENHANCES ANTI-TUMOR RESPONSES AND PROMOTES TUMOR INFILTRATION
por: Gong, Ying, et al.
Publicado: (2023)

T cells fail to develop in the human skin-cell explants system; an inconvenient truth
por: Meek, Bob, et al.
Publicado: (2011)

Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A
por: Sarkar, Subhashis, et al.
Publicado: (2015)

Tuning Natural Killer Cell Anti-multiple Myeloma Reactivity by Targeting Inhibitory Signaling via KIR and NKG2A
por: Mahaweni, Niken M., et al.
Publicado: (2018)

Inhibitory receptors for HLA class I as immune checkpoints for natural killer cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
por: Beelen, Nicky A., et al.
Publicado: (2022)

Daratumumab augments alloreactive natural killer cell cytotoxicity towards CD38+ multiple myeloma cell lines in a biochemical context mimicking tumour microenvironment conditions
por: Mahaweni, Niken M., et al.
Publicado: (2018)

A comprehensive overview of FCGR3A gene variability by full-length gene sequencing including the identification of V158F polymorphism
por: Mahaweni, Niken M., et al.
Publicado: (2018)

Ascorbic acid serum levels are reduced in patients with hematological malignancies
por: Huijskens, Mirelle J.A.J., et al.
Publicado: (2016)

Activated Natural Killer Cells Withstand the Relatively Low Glucose Concentrations Found in the Bone Marrow of Multiple Myeloma Patients
por: Ehlers, Femke A. I., et al.
Publicado: (2021)

Exploring the potential of combining IL-2-activated NK cells with an anti-PDL1 monoclonal antibody to target multiple myeloma-associated macrophages
por: Ehlers, Femke A. I., et al.
Publicado: (2023)

Pathogen recognition by NK cells amplifies the pro-inflammatory cytokine production of monocyte-derived DC via IFN-γ
por: Oth, Tammy, et al.
Publicado: (2018)

Polymorphic differences within HLA‐C alleles contribute to alternatively spliced transcripts lacking exon 5
por: Ehlers, Femke A. I., et al.
Publicado: (2022)

Monitoring the Initiation and Kinetics of Human Dendritic Cell-Induced Polarization of Autologous Naive CD4(+) T Cells
por: Oth, Tammy, et al.
Publicado: (2014)

P1570: SARS-COV-2 HUMORAL AND CELLULAR VACCINATION RESPONSE IN PATIENTS WITH LYMPHOID HAEMATOLOGICAL MALIGNANCIES
por: Boerenkamp, L. S., et al.
Publicado: (2022)

ADCC-Inducing Antibody Trastuzumab and Selection of KIR-HLA Ligand Mismatched Donors Enhance the NK Cell Anti-Breast Cancer Response
por: Ehlers, Femke A. I., et al.
Publicado: (2021)

Long-lasting antitumor effects provided by radiotherapy combined with the immunocytokine L19-IL2
por: Rekers, Nicolle H, et al.
Publicado: (2015)

Antibody-dependent cellular cytotoxicity-inducing antibodies enhance the natural killer cell anti-cancer response against patient-derived pancreatic cancer organoids
por: Beelen, Nicky A., et al.
Publicado: (2023)

NKG2A Expression Is Not per se Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an In Vitro System Mimicking the Tumor Microenvironment
por: Mahaweni, Niken M., et al.
Publicado: (2018)

Targeted antigen delivery by an anti-class II MHC VHH elicits focused αMUC1(Tn) immunity
por: Fang, Tao, et al.
Publicado: (2017)

Vitamin D: An overview of vitamin D status and intake in Europe
por: Spiro, A, et al.
Publicado: (2014)

The immunocytokine L19-IL2: An interplay between radiotherapy and long-lasting systemic anti-tumour immune responses
por: Rekers, Nicolle H., et al.
Publicado: (2018)

Concordance in measurable residual disease result after first and second induction cycle in acute myeloid leukemia: An outcome- and cost-analysis
por: Tettero, Jesse M., et al.
Publicado: (2022)

Vitamin D: An overview
por: Clifopoulos, Chris
Publicado: (2017)

The anti-inflammatory mechanisms of Hsp70
por: Borges, Thiago J., et al.
Publicado: (2012)

From Farm to Pharma: An Overview of Industrial Heparin Manufacturing Methods
por: van der Meer, Jan-Ytzen, et al.
Publicado: (2017)

The Immunomodulatory Role of Hypoxic Tumor-Derived Extracellular Vesicles
por: Beaumont, Joel E. J., et al.
Publicado: (2022)

Natural killer cell profiles in recurrent pregnancy loss: Increased expression and positive associations with TACTILE and LILRB1
por: Habets, Denise H. J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_449daqalb0ablccbbv0tu4m907